Genome-wide studies have identified some association between NAFLD susceptibility and Transmembrane 6 superfamily member 2 (TM6SF2) and Patatin-like phospholipase domain-containing 3 (PNPLA3) [5,15]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.